Myvelpa

Description

Ingredients:

Sofosbuvir, Velpatasvir

Excipients:

Drug Excipients: Copovidone, Lactose Monohydrate, Microcrystalline Sodium (Ceolus UF 702), Microcrystalline Cellulose (Avicel PH 112), Croscarmellose Sodium, Colloidal Silicon Dioxide, Magnesium Stearate Coating Systems Excipients (Green TC-510031): Polyvinyl Alcohol, Polyethylene Glycol, Titanium Dioxide, Talc, Indigo carmine Aluminum lake, Iron Oxide Yellow

Assign:

Velpatasvir/sofosbuvir tablets are indicated for the treatment of chronic hepatitis C virus infection in adults.

Expiry date:

24 months

Packing:

Bottle of 28 tablets

Preservation:

Drugs are to be stored in a cool and dry place, below 30°C. Store in original packaging. Keep out of reach of children. Read the user manual carefully before use.

Brand Origin:

India

Products Details:

Amount use

Take 1 tablet (400mg sofosbuvir/100mg velpatasvir) daily, with or without food.

Contraindications:

Patients with hypersensitivity to the components of the drug and pregnant women.

Careful and informed

- Do not use velpatasvir/sofosbuvir tablets concurrently with other medicinal products containing sofosbuvir. - Bradycardia and severe heart block. - The patient has failed a treatment regimen containing NS5A. - Patients with kidney failure. - The patient is taking moderate P-gp and CYP inducers. - Use in combination with HIV treatment regimens. - Patients are coinfected with HCV and HBV (hepatitis B). - Patients with cirrhosis of the liver CPT index C. - Liver transplant patient.

See details